JP2022515820A5 - - Google Patents
Info
- Publication number
- JP2022515820A5 JP2022515820A5 JP2021537704A JP2021537704A JP2022515820A5 JP 2022515820 A5 JP2022515820 A5 JP 2022515820A5 JP 2021537704 A JP2021537704 A JP 2021537704A JP 2021537704 A JP2021537704 A JP 2021537704A JP 2022515820 A5 JP2022515820 A5 JP 2022515820A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- pharmaceutical composition
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2018146029A RU2711871C3 (ru) | 2018-12-25 | Моноклональные антитела, которые специфически связываются с участком бета цепи семейства TRBV-9 Т-клеточного рецептора человека, и способы их применения | |
| RU2018146029 | 2018-12-25 | ||
| PCT/RU2019/050257 WO2020139171A1 (ru) | 2018-12-25 | 2019-12-24 | Моноклональные антитела, специфически связывающиеся с trbv-9 человека |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022515820A JP2022515820A (ja) | 2022-02-22 |
| JP2022515820A5 true JP2022515820A5 (cg-RX-API-DMAC7.html) | 2023-01-10 |
| JP7507160B2 JP7507160B2 (ja) | 2024-06-27 |
Family
ID=69184146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021537704A Active JP7507160B2 (ja) | 2018-12-25 | 2019-12-24 | ヒトtrbv9に特異的に結合するモノクローナル抗体 |
Country Status (26)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2694412C9 (ru) | 2017-12-25 | 2019-09-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) | Моноклональные антитела и способы их применения |
| US12247060B2 (en) | 2018-01-09 | 2025-03-11 | Marengo Therapeutics, Inc. | Calreticulin binding constructs and engineered T cells for the treatment of diseases |
| EP3765517A1 (en) | 2018-03-14 | 2021-01-20 | Elstar Therapeutics, Inc. | Multifunctional molecules that bind to calreticulin and uses thereof |
| WO2020010250A2 (en) | 2018-07-03 | 2020-01-09 | Elstar Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| JP7579795B2 (ja) | 2019-02-21 | 2024-11-08 | マレンゴ・セラピューティクス,インコーポレーテッド | NKp30に結合する抗体分子およびその使用 |
| AU2020226893B2 (en) | 2019-02-21 | 2025-02-27 | Marengo Therapeutics, Inc. | Multifunctional molecules that bind to T cell related cancer cells and uses thereof |
| WO2021138474A2 (en) | 2020-01-03 | 2021-07-08 | Marengo Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| TW202417487A (zh) * | 2022-08-18 | 2024-05-01 | 俄羅斯聯邦商拜奧卡德聯合股份公司 | 治療在t細胞受體內帶有trbv9節段的t淋巴細胞所介導的疾病或病症之方法 |
| KR20260085152A (ko) * | 2023-10-04 | 2026-06-08 | 조인트 스탁 컴퍼니 "바이오케드" | 인간 tcr 도메인의 trbv5-1 세그먼트에 결합하는 항체 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5766947A (en) | 1988-12-14 | 1998-06-16 | Astra Ab | Monoclonal antibodies reactive with an epitope of a Vβ3.1 variable region of a T cell receptor |
| US5223426A (en) | 1988-12-15 | 1993-06-29 | T Cell Sciences, Inc. | Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor |
| AU2002368077B2 (en) | 2001-07-12 | 2010-03-04 | Jefferson Foote | Super humanized antibodies |
| CA2765949C (en) * | 2009-06-25 | 2016-03-29 | Fred Hutchinson Cancer Research Center | Method of measuring adaptive immunity |
| TW201208701A (en) | 2010-07-12 | 2012-03-01 | Daiichi Sankyo Co Ltd | Anti-EPHA2 antibodies and uses thereof |
| US20130273089A1 (en) | 2011-11-03 | 2013-10-17 | Tolera Therapeutics, Inc. | Antibody and methods for selective inhibition of t-cell responses |
| DK2991683T3 (da) * | 2013-05-02 | 2019-11-04 | Glykos Finland Oy | Konjugater af et glykoprotein eller en glykan med en toksisk ladning |
| EP3202784A1 (en) * | 2016-02-08 | 2017-08-09 | Polybiocept AB | T-cell receptor sequences for active immunotherapy |
| JP6989138B2 (ja) | 2016-06-17 | 2022-01-05 | メディジーン イミュノテラピーズ ゲーエムベーハー | T細胞受容体及びその使用 |
| AU2017356322B2 (en) * | 2016-11-14 | 2023-09-21 | Fred Hutchinson Cancer Center | High affinity merkel cell polyomavirus T antigen-specific TCRs and uses thereof |
| JP7162607B2 (ja) * | 2017-02-27 | 2022-10-28 | 中外製薬株式会社 | 抗hla-dq2.5/8抗体およびセリアック病の治療のためのその使用 |
| CN107502671B (zh) * | 2017-10-12 | 2020-05-05 | 中国医学科学院肿瘤医院 | 利用trbv家族成员预测曲妥珠单抗新辅助治疗乳腺癌患者疗效试剂盒及其应用 |
| RU2694412C9 (ru) | 2017-12-25 | 2019-09-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) | Моноклональные антитела и способы их применения |
-
2019
- 2019-12-23 AR ARP190103841A patent/AR117735A1/es unknown
- 2019-12-24 MX MX2021007718A patent/MX2021007718A/es unknown
- 2019-12-24 WO PCT/RU2019/050257 patent/WO2020139171A1/ru not_active Ceased
- 2019-12-24 CR CR20210353A patent/CR20210353A/es unknown
- 2019-12-24 JP JP2021537704A patent/JP7507160B2/ja active Active
- 2019-12-24 BR BR112021012550-7A patent/BR112021012550A2/pt unknown
- 2019-12-24 US US17/417,570 patent/US12297269B2/en active Active
- 2019-12-24 PE PE2021001079A patent/PE20211792A1/es unknown
- 2019-12-24 MA MA53688A patent/MA53688B1/fr unknown
- 2019-12-24 TW TW108147433A patent/TWI914298B/zh active
- 2019-12-24 SM SM20260227T patent/SMT202600227T1/it unknown
- 2019-12-24 CN CN201980092914.6A patent/CN113692412B/zh active Active
- 2019-12-24 EP EP26157540.1A patent/EP4721817A2/en active Pending
- 2019-12-24 SG SG11202106974SA patent/SG11202106974SA/en unknown
- 2019-12-24 RS RS20260561A patent/RS68101B1/sr unknown
- 2019-12-24 CA CA3124800A patent/CA3124800A1/en active Pending
- 2019-12-24 MY MYPI2021003582A patent/MY206214A/en unknown
- 2019-12-24 EA EA202100199A patent/EA202100199A1/ru unknown
- 2019-12-24 EP EP19904442.1A patent/EP3904387B1/en active Active
- 2019-12-24 KR KR1020217023567A patent/KR102974826B1/ko active Active
-
2021
- 2021-06-23 CO CONC2021/0008204A patent/CO2021008204A2/es unknown
- 2021-06-24 CL CL2021001704A patent/CL2021001704A1/es unknown
- 2021-06-24 IL IL284367A patent/IL284367A/en unknown
- 2021-06-24 JO JOJO/P/2021/0168A patent/JOP20210168B1/ar active
- 2021-06-24 EC ECSENADI202146332A patent/ECSP21046332A/es unknown
- 2021-06-24 ZA ZA2021/04356A patent/ZA202104356B/en unknown
- 2021-06-25 PH PH12021551535A patent/PH12021551535A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022532274A5 (cg-RX-API-DMAC7.html) | ||
| EP3645742B1 (en) | Anti-ror1 antibodies and methods of making and using thereof | |
| RU2504553C2 (ru) | Антитела к her | |
| JP2021058215A (ja) | Ror1癌の治療および転移の阻害に使用するための抗体およびワクチン | |
| RU2451689C2 (ru) | Новые антипролиферативные антитела | |
| Li et al. | CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells | |
| CN112513089A (zh) | 抗cd73抗体、其抗原结合片段及应用 | |
| JP2020532965A5 (cg-RX-API-DMAC7.html) | ||
| RU2013153592A (ru) | Анти-mif антитела | |
| RU2013102225A (ru) | АНТИТЕЛА ПРОТИВ Axl И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| JP2016520520A5 (cg-RX-API-DMAC7.html) | ||
| JP2014503189A5 (cg-RX-API-DMAC7.html) | ||
| HRP20240102T1 (hr) | Monoklonsko protutijelo koje antagonizira i inhibira vezanje između humanog pd-1 antigena i njegovog liganda, postupak njegove priprave i primjena | |
| JP2013520984A5 (cg-RX-API-DMAC7.html) | ||
| US20250313630A1 (en) | Ph-selective anti-cd3 antibodies and use of the same | |
| SA515360248B1 (ar) | أجسام مضادة cd26 واستخداماتها | |
| AU2019301336B2 (en) | Prevention or treatment method for peripheral neuropathy or pain accompanying disease in which peripheral neuropathy or astrocyte disorder is recognized | |
| WO2017186182A1 (en) | Humanized anti-basigin antibodies and the use thereof | |
| JP2022516071A5 (cg-RX-API-DMAC7.html) | ||
| JP2018502068A5 (cg-RX-API-DMAC7.html) | ||
| JP2009524428A5 (cg-RX-API-DMAC7.html) | ||
| CN114805570B (zh) | 一种抗人ace2单克隆抗体及其应用 | |
| CN114149498B (zh) | 抗人emc10的单克隆抗体在防治2型糖尿病中的应用 | |
| WO2014139425A1 (zh) | 一种抗Blys的单克隆抗体及含有该抗体的药物组合物 | |
| IL277899B1 (en) | Methods and compositions for treating yellow fever |